Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    "Menlo Therapeutics Inc."
Show Display Options
Rank Status Study
1 Recruiting Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
Conditions: Pruritus;   Burns
Interventions: Drug: Serlopitant;   Drug: Placebo
2 Recruiting Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Conditions: Pruritus;   Atopic Dermatitis
Interventions: Drug: Serlopitant High Dose;   Drug: Placebo Oral Tablet;   Drug: Serlopitant Low Dose
3 Completed A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
Condition: Prurigo Nodularis
Interventions: Drug: serlopitant;   Drug: Placebo
4 Completed VPD-737 for Treatment of Chronic Pruritus
Condition: Chronic Pruritus
Interventions: Drug: VPD-737;   Drug: Placebo
5 Recruiting Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients
Conditions: Epidermolysis Bullosa;   Pruritus
Interventions: Drug: VPD-737;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.